TNF receptor II fusion protein with tandemly repeated Fc domains.
TNF receptor II fusion protein with tandemly repeated Fc domains.
复制标题
具有串联重复 Fc 结构域的 TNF 受体 II 融合蛋白。
DOI:
10.1093/jb/mvq149
复制
发表时间:
2011
影响因子:
2.7
通讯作者:
Y. Masuho
中科院分区:
文献类型:
--
作者:
H. Nagashima;Kaname Kaneko;Ayaka Yamanoi;Sotaro Motoi;S. Konakahara;J. Kohroki;Y. Masuho
The extracellular domain of tumour necrosis factor (TNF) receptor II fused with the human IgG1 Fc region (TNFRII-Fc), as well as antibodies against TNF, has been used to treat rheumatoid arthritis. However, TNFRII-Fc is less effective than these antibodies in terms of antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC) against cells bearing TNF on the cell surface. We hypothesized that these activities could be increased by fusing TNFRII with tandemly repeated Fc (TNFRII-Fc-Fc). The affinities of TNFRII-Fc-Fc for soluble TNF-α and transmembrane TNF-α and the TNF-α cytotoxicity-inhibitory activity were as potent as those of TNFRII-Fc. TNFRII-Fc-Fc showed much higher binding avidity for Fcγ receptors than TNFRII-Fc and was more potent in terms of both ADCC and CDC against cells expressing transmembrane TNF-α. TNFRII-Fc-Fc of 80 kDa, as well as TNFRII-Fc-Fc of 200 kDa, was detected. TNFRII-Fc-Fc (80 kDa) was as potent as TNFRII-Fc in terms of both ADCC and CDC. These results suggest that Fc multimerization of receptor-Fc fusion proteins can augment effector functions such as ADCC and CDC, and thereby have the potential to provide a superior therapeutic effect. This may be the case not only for TNFRII-Fc but also for other receptor-Fc fusion proteins.
登录
查看更多内容
影响因子:
45.3
作者:
Weng, WK;Levy, R
通讯作者:
Levy, R
影响因子:
20.3
作者:
Byrd, JC;Kitada, S;Reed, JC
通讯作者:
Reed, JC
影响因子:
20.3
作者:
Bowles, Julie A.;Wang, Siao-Yi;Weiner, George J.
通讯作者:
Weiner, George J.
DOI:
--
发表时间:
1993
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Vance,BA;Huizinga,TW;Wardwell,K;Guyre,PM
通讯作者:
Guyre,PM